The induction of EMT entails a reduction or loss of the ability to synthesize cytokeratins and E-cadherin by the epithelial and tumor cells, but the appearance of the ability to synthesize vimentin, Snail, smooth-muscle actin and other markers of EMT as well as an increasing expression of the genes encoding matrix metalloproteinases. The gene discussed is CDH1; the disease is neoplasm.